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A 64-year-old man was diagnosed with a large tumor of the anterior mediastinum (Fig. 1), which, by ultrasound-
guided needle aspiration, was initially characterized as an 
atypical carcinoid (neuroendocrine tumor [NET]; mitotic 
count 2-20 per 10 high power fields and/or 3-20% Ki67 index 
[G2 (NET G2)]; MIB1-Prolifarations Index 3%–8%, positive 
chromogranin A). The patient was referred to our department 
for further investigation and surgical resection. The resection 
of the tumor was performed in January 2011. The left phrenic 
nerve, both mammary arteries, the brachiocephalic vein, and 
a part of the pericardium were engulfed by the tumor and were 
removed. A complete dissection of the tumor from the supe-
rior vena cava was not possible, so a very small amount of 
tumor tissue was inevitably left at the junction of the excised 
brachiocephalic vein with the superior vena cava. Because 
of the R2 resection and the chronic renal insufficiency only 
additional radiotherapy was suggested. The patient having 
completed the suggested radiotherapy (40Gy) remains with-
out recurrence of the tumor or metastases at 15 months after 
surgery. Macroscopically, the tumor was a white-yellowish, 
partly encapsulated, soft, elastic nodular mass and weighed 
1770 g. The cut surface showed lobules with hemorrhage and 
myxoid as well as cystic areas. Microscopic core features are 
characterized in Figure 2.
Case reports of adult neuroblastoma (ANB) occurring in 
nonpediatric patients more than 18 years of age are rare, with 
less than 50 published cases. To our knowledge only 21 cases 
of mediastinal ANB, including three thymic neuroblastomas, 
have been reported.1 ANB does not show a sex predilection.2 
The site of the primary tumor purely reflects the distribution 
of the sympathetic nervous system, with the distribution being 
similar among adults and children.2,3 In our case the tumor 
might originate somewhere along the course of the sympa-
thetic aortic plexus or the phrenic nerve. A thymic origin of 
the neuroblastoma could not be demonstrated. Alternatively, 
mediastinal ANB can originate from a preexisting mediastinal 
teratoma, which also could not be demonstrated. Figure 3 gives 
a synopsis over the immunohistochemical differential diagno-
sis. Because of the positive staining for Chromogranin A, these 
tumors can be mistaken for carcinoid tumors. However, the 
different cellular structure, the necrosis, and the mitotic/pro-
liferation index, as well as immunohistochemical panel usually 
helps avoiding a misdiagnosis.4 Tumors of this size are in gen-
eral inoperable especially without prior treatment. The false 
initial diagnosis as atypical carcinoid lead us to an attempt of 
operative resection. In spite of the R2 resection and after adju-
vant radiotherapy the patient remains tumor free 15 months 
after surgery. There is no consensus regarding the treatment of 
ANB. Some centers apply similar protocols for the treatment 
of the tumor in children and adults. Treatment options include 
surgical resection, radiotherapy, or chemotherapy and the 
most active therapeutic agents used alone or in combination 
include cyclophosphamide, cisplatin, doxorubicin, carbopla-
tin, and ifosfamide.5 Regarding prognosis and survival, there 
is a trend of improvement in survival in recent decades, which 
may reflect advances in treatment options. Patients with local-
ized disease or regionally advanced disease had higher survival 
rates than those with advanced metastatic disease.
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FIGURE 1.  Magnetic resonance 
imaging (A, B) and posteroanterior 
chest radiograph (C) demonstrating 
an extensive tumor mass occupying 
the anterior mediastinum. The tumor 
extends from the upper thoracic 
aperture cranially almost to the 
diaphragm caudally (A), with shifting 
of the major vessels posteriorly (B). 
Postoperative posteroanterior chest 
radiograph after successful tumor 
resection (D).
FIGURE 2. A, Tumor overview (hematoxylin and eosin stain-
ing; red bar = 100 μm): extended areas of necrosis in the 
center of the tumor. Parts of the connective tissue capsule and 
some fat tissue in the periphery. B, Tumor (higher magnifica-
tion; hematoxylin and eosin staining): relatively small tumor 
cells with hyperchromatic nuclei are partially arranged in 
single files. A neuropil-like matrix can be noted in the back-
ground embedding the tumor cells. C, Immunohistochemistry 
( synaptophysin): positive reaction of the neuropil-like matrix, 
but not of the tumor cells, vessels, the fibrous capsule, and adi-
pose tissue. D,Immunohistochemistry (neuron-specific enolase): 
faint reactivity of the neuropil-like matrix and a weak positiv-
ity of the tumor-cell cytoplasms. E, Immunohistochemistry 
( chromogranin A): strong reactivity of the neuropil-like Matrix, 
but not of the tumor cells, vessels, the fibrous capsule, and 
adipose tissue. Focally, tumor invasion of the surrounding 
adipose tissue is observed (arrow). F Immunohistochemistry 
(CD 56): strong reactivity of the neuropil-like matrix and single 
tumor cells.
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FIGURE 3.  Immunohistochemical profile of neuroblastoma and possible differential diagnoses. (Annotation: “−” negative, “+” 
positive, “±” variable positive or negative [“−” to “++++” describes the relative quantity of cases featured in the literature but 
not the strength of staining]). NSE, neurone specific enolase; PNET, primitive neuroectodermal tumor.
